Everett Harris & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.82M | Buy |
283,402
+3,228
| +1% | +$84.4K | 0.08% | 69 |
|
|
2026
Q1 | $7.87M | Buy |
280,174
+10,509
| +4% | +$280K | 0.1% | 61 |
|
|
2025
Q4 | $6.71M | Buy |
269,665
+1,285
| +0.5% | +$32.4K | 0.08% | 69 |
|
|
2025
Q3 | $6.84M | Buy |
268,380
+1,148
| +0.4% | +$28.3K | 0.08% | 65 |
|
|
2025
Q2 | $6.48M | Buy |
267,232
+30,471
| +13% | +$711K | 0.08% | 67 |
|
|
2025
Q1 | $6M | Buy |
236,761
+12,508
| +6% | +$327K | 0.08% | 69 |
|
|
2024
Q4 | $5.95M | Buy |
224,253
+5,909
| +3% | +$160K | 0.08% | 70 |
|
|
2024
Q3 | $6.32M | Buy |
218,344
+38,870
| +22% | +$1.13M | 0.08% | 69 |
|
|
2024
Q2 | $5.02M | Buy |
179,474
+34,752
| +24% | +$957K | 0.06% | 69 |
|
|
2024
Q1 | $4.02M | Buy |
144,722
+26,812
| +23% | +$744K | 0.05% | 78 |
|
|
2023
Q4 | $3.39M | Sell |
117,910
-260
| -0.2% | -$7.86K | 0.05% | 81 |
|
|
2023
Q3 | $3.92M | Buy |
118,170
+93
| +0.1% | +$3.29K | 0.06% | 74 |
|
|
2023
Q2 | $4.33M | Buy |
118,077
+4,274
| +4% | +$166K | 0.07% | 71 |
|
|
2023
Q1 | $4.64M | Buy |
113,803
+330
| +0.3% | +$14.3K | 0.08% | 68 |
|
|
2022
Q4 | $5.81M | Sell |
113,473
-32,226
| -22% | -$1.55M | 0.1% | 63 |
|
|
2022
Q3 | $6.38M | Buy |
145,699
+1,845
| +1% | +$89.7K | 0.12% | 60 |
|
|
2022
Q2 | $7.54M | Buy |
143,854
+7,667
| +6% | +$391K | 0.13% | 58 |
|
|
2022
Q1 | $7.05M | Buy |
136,187
+95
| +0.1% | +$4.93K | 0.1% | 66 |
|
|
2021
Q4 | $8.04M | Buy |
136,092
+1,220
| +0.9% | +$60.4K | 0.11% | 63 |
|
|
2021
Q3 | $5.8M | Buy |
134,872
+8,305
| +7% | +$368K | 0.09% | 68 |
|
|
2021
Q2 | $4.96M | Buy |
126,567
+8,121
| +7% | +$316K | 0.08% | 71 |
|
|
2021
Q1 | $4.29M | Buy |
118,446
+6,895
| +6% | +$245K | 0.07% | 73 |
|
|
2020
Q4 | $4.11M | Sell |
111,551
-1,897
| -2% | -$69.6K | 0.07% | 74 |
|
|
2020
Q3 | $3.95M | Buy |
113,448
+3,574
| +3% | +$125K | 0.08% | 73 |
|
|
2020
Q2 | $3.41M | Buy |
109,874
+2,891
| +3% | +$98.2K | 0.08% | 73 |
|
|
2020
Q1 | $3.31M | Buy |
106,983
+47,313
| +79% | +$1.61M | 0.09% | 70 |
|
|
2019
Q4 | $2.22M | Buy |
59,670
+603
| +1% | +$21.5K | 0.05% | 104 |
|
|
2019
Q3 | $2.01M | Sell |
59,067
-16,140
| -21% | -$587K | 0.05% | 102 |
|
|
2019
Q2 | $3.09M | Sell |
75,207
-3,225
| -4% | -$128K | 0.08% | 80 |
|
|
2019
Q1 | $3.16M | Buy |
78,432
+930
| +1% | +$37.2K | 0.08% | 81 |
|
|
2018
Q4 | $3.21M | Hold |
77,502
| – | – | 0.09% | 72 |
|
|
2018
Q3 | $3.24M | Sell |
77,502
-467
| -0.6% | -$18K | 0.08% | 75 |
|
|
2018
Q2 | $2.68M | Buy |
77,969
+209
| +0.3% | +$7.14K | 0.07% | 81 |
|
|
2018
Q1 | $2.62M | Buy |
77,760
+7,153
| +10% | +$246K | 0.07% | 81 |
|
|
2017
Q4 | $2.43M | Sell |
70,607
-712
| -1% | -$24.3K | 0.07% | 92 |
|
|
2017
Q3 | $2.42M | Buy |
71,319
+95
| +0.1% | +$3.05K | 0.07% | 94 |
|
|
2017
Q2 | $2.27M | Buy |
71,224
+438
| +0.6% | +$13.8K | 0.07% | 93 |
|
|
2017
Q1 | $2.3M | Sell |
70,786
-4,678
| -6% | -$147K | 0.08% | 89 |
|
|
2016
Q4 | $2.33M | Sell |
75,464
-455
| -0.6% | -$13.9K | 0.08% | 87 |
|
|
2016
Q3 | $2.44M | Sell |
75,919
-3,073
| -4% | -$103K | 0.09% | 98 |
|
|
2016
Q2 | $2.64M | Sell |
78,992
-5,061
| -6% | -$162K | 0.09% | 91 |
|
|
2016
Q1 | $2.36M | Hold |
84,053
| – | – | 0.09% | 102 |
|
|
2015
Q4 | $2.57M | Sell |
84,053
-946
| -1% | -$29.8K | 0.09% | 96 |
|
|
2015
Q3 | $2.53M | Sell |
84,999
-347
| -0.4% | -$11.1K | 0.09% | 94 |
|
|
2015
Q2 | $2.71M | Buy |
85,346
+347
| +0.4% | +$11.3K | 0.1% | 88 |
|
|
2015
Q1 | $2.81M | Sell |
84,999
-486
| -0.6% | -$15.5K | 0.1% | 85 |
|
|
2014
Q4 | $2.53M | Buy |
85,485
+738
| +0.9% | +$21.2K | 0.09% | 93 |
|
|
2014
Q3 | $2.38M | Buy |
84,747
+1,913
| +2% | +$53.7K | 0.09% | 93 |
|
|
2014
Q2 | $2.33M | Buy |
82,834
+54
| +0.1% | +$1.54K | 0.09% | 89 |
|
|
2014
Q1 | $2.52M | Buy |
82,780
+6,176
| +8% | +$184K | 0.09% | 81 |
|
|
2013
Q4 | $2.23M | Buy |
76,604
+8,503
| +12% | +$247K | 0.08% | 82 |
|
|
2013
Q3 | $1.86M | Hold |
68,101
| – | – | 0.08% | 81 |
|
|
2013
Q2 | $1.81M | Buy |
+68,101
| New | +$1.88M | 0.08% | 82 |
|
Other funds holding PFE
Everett Harris & Co's PFE Position: Q2 2026 in Review
Everett Harris & Co increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $84.4K and bringing the position to 283,402 shares worth $6.82M. The position accounts for 0.08% of the portfolio, ranked #69.
Everett Harris & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.04M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Everett Harris & Co held 283,402 shares of Pfizer worth $6.82M as of Q2 2026.
- Everett Harris & Co bought 3,228 Pfizer shares in Q2 2026, an estimated $84.4K.
- Pfizer made up 0.08% of Everett Harris & Co's portfolio in Q2 2026, its #69 holding.
- Everett Harris & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Everett Harris & Co's Pfizer position peaked at $8.04M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.